Patent application number | Description | Published |
20100135550 | METHOD, DEVICE AND SYSTEM FOR THERMOGRAPHY - A method of determining an internal three-dimensional thermally distinguishable region in the living body is disclosed. The method comprises obtaining a synthesized thermospatial image defined over a three-dimensional spatial representation of the living body and having thermal data arranged gridwise over a surface of the three-dimensional spatial representation in a plurality of picture-elements each represented by a intensity value over the grid. The method further comprises searching over the grid for at least one set of picture-elements represented by generally similar intensity values. For at least a few sets of picture-elements, the method defines a plurality of loci, each locus being associated with at least a pair of picture-elements of the set and defined such that each point of the locus is at equal thermal distances from individual picture-elements of the pair. The plurality of loci is used for determining the internal three-dimensional thermally distinguishable region. | 06-03-2010 |
20110021944 | METHOD APPARATUS AND SYSTEM FOR ANALYZING THERMAL IMAGES - A method of identifying a thermally distinguishable region in a living body is disclosed. The method comprises determining transient thermal history of a surface of the living body, and estimating a location or presence of the thermally distinguishable region in the living body based on the transient thermal history. | 01-27-2011 |
20140112561 | METHOD APPARATUS AND SYSTEM FOR ANALYZING IMAGES - A method of analyzing a thermal image of a body section is disclosed. The method comprises obtaining a thermospatial representation of the body section, calculating a surface integral of the thermal data over the surface, and determining the likelihood that a thermally distinguishable region is present in the body section, based on a value of the surface integral. | 04-24-2014 |
Patent application number | Description | Published |
20090124557 | Compositions and methods for treating cancer - A composition which comprises a chimeric polypeptide is provided. The chimeric polypeptide having a flagellin amino acid sequence and a mucin 1 amino acid sequence which includes at least a 7 amino acid sequence of the mucin 1 tandem repeat which can be used to elicit an immune response against MUC1—expressing cancerous cells. Also provided is a method of treating cancer such as a cancer of a glandular epithelium in which MUC1 is overexpressed using the composition of the present invention. | 05-14-2009 |
20100021489 | Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection - Polynucleotides and polypeptides which participate in influenza virus infection of cells and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and antibodies directed thereagainst for diagnosing, treating and preventing influenza virus infection. | 01-28-2010 |
20130079390 | NUCLEIC ACID MOLECULES, POLYPEPTIDES, ANTIBODIES AND COMPOSITIONS FOR TREATING AND DETECTING INFLUENZA VIRUS INFECTION - Polynucleotides and polypeptides which participate in influenza virus infection of cells and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and antibodies directed thereagainst for diagnosing, treating and preventing influenza virus infection. | 03-28-2013 |
Patent application number | Description | Published |
20090130121 | Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders - The present invention relates to the use of random or ordered copolymers including the known copolymer glatiramer (also known as Copolymer 1) and Copolymer 1-related heteropolymers or ordered peptides, for treating or preventing cardiovascular diseases and disorders. | 05-21-2009 |
20090191173 | Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 - A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent. | 07-30-2009 |
20090304730 | INFLUENZA VACCINE - The present invention relates to influenza vaccines for human and veterinary use. In particular, the present invention provides a vaccine able to effect long term and cross-strain protection by including at least two influenza virus epitopes expressed as a chimeric polypeptide wherein at least one epitope is influenza A virus matrix protein epitope and the second epitope is a haemagglutinin peptide epitope. | 12-10-2009 |
20100298227 | Treatment of autoimmune conditions with Copolymer 1 and related copolymers - The present invention is directed to polypeptides containing at least three amino acids randomly joined in a linear array; wherein at least one of the three amino acids is an aromatic amino acid, at least one of the three amino acids is a charged amino acid and at least one amino acid is an aliphatic amino acid. In a preferred embodiment the polypeptide contains three or four of the following amino acids: tyrosine, alanine, glutamic acid or lysine. According to the present invention, the present polypeptides bind to antigen presenting cells, purified human lymphocyte antigens (HLA) and/or Copolymer 1-specific T cells. Moreover, according to the present invention, these polypeptides can be formulated into pharmaceutical compositions for treating autoimmune disease. The present invention further contemplates methods of treating an autoimmune disease in a mammal by administering a pharmaceutically effective amount of any one of the present polypeptides to the mammal. | 11-25-2010 |
20120077754 | COPOLYMER-1 IMPROVEMENTS IN COMPOSITIONS OF COPOLYMERS - The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons. | 03-29-2012 |
20120135016 | INDUCTION OF NEUROGENESIS AND STEM CELL THERAPY IN COMBINATION WITH COPOLYMER 1 - A method for inducing and enhancing neurogenesis and/or oligodendrogenesis from endogenous as well as from exogenously administered stem cells comprises administering to an individual in need thereof an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide, a Copolymer 1-related peptide, and activated T cells which have been activated by Copolymer 1, a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide. The method is particularly useful for stem cell therapy in combination with the agent. | 05-31-2012 |
20150030560 | TREATMENT OF AUTOIMMUNE CONDITIONS WITH COPOLYMER 1 AND RELATED COPOLYMERS - The present invention is directed to polypeptides containing at least three amino acids randomly joined in a linear array; wherein at least one of the three amino acids is an aromatic amino acid, at least one of the three amino acids is a charged amino acid and at least one amino acid is an aliphatic amino acid. In a preferred embodiment the polypeptide contains three or four of the following amino acids: tyrosine, alanine, glutamic acid or lysine. According to the present invention, the present polypeptides bind to antigen presenting cells, purified human lymphocyte antigens (HLA) and/or Copolymer 1-specific T cells. Moreover, according to the present invention, these polypeptides can be formulated into pharmaceutical compositions for treating autoimmune disease. The present invention further contemplates methods of treating an autoimmune disease in a mammal by administering a pharmaceutically effective amount of any one of the present polypeptides to the mammal. | 01-29-2015 |